Your browser doesn't support javascript.
loading
Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial.
O'Callaghan, Finbar J K; Edwards, Stuart W; Alber, Fabienne Dietrich; Hancock, Eleanor; Johnson, Anthony L; Kennedy, Colin R; Likeman, Marcus; Lux, Andrew L; Mackay, Mark; Mallick, Andrew A; Newton, Richard W; Nolan, Melinda; Pressler, Ronit; Rating, Dietz; Schmitt, Bernhard; Verity, Christopher M; Osborne, John P.
Afiliación
  • O'Callaghan FJ; Institute of Child Health, University College London, London, UK; Children's Department, Royal United Hospitals Bath NHS Foundation Trust, Combe Park, Bath, UK. Electronic address: f.o'callaghan@ucl.ac.uk.
  • Edwards SW; Children's Department, Royal United Hospitals Bath NHS Foundation Trust, Combe Park, Bath, UK; Department for Health, University of Bath, Claverton Down, Bath, UK.
  • Alber FD; Division of Neurology/Neuropsychology, University Children's Hospital, Zurich, Switzerland.
  • Hancock E; Children's Department, Royal United Hospitals Bath NHS Foundation Trust, Combe Park, Bath, UK.
  • Johnson AL; Medical Research Council Clinical Trials Unit at UCL, Aviation House, London, UK.
  • Kennedy CR; Clinical Neurosciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK.
  • Likeman M; Department of Paediatric Radiology, Bristol Royal Hospital for Children, Bristol, UK.
  • Lux AL; Department of Paediatric Neurology, Bristol Royal Hospital for Children, Bristol, UK.
  • Mackay M; Neurology Department, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.
  • Mallick AA; Department of Paediatric Neurology, Bristol Royal Hospital for Children, Bristol, UK.
  • Newton RW; Department of Neurology, Royal Manchester Children's Hospital, Manchester, UK.
  • Nolan M; Starship Children's Health, Auckland, New Zealand.
  • Pressler R; UCL Institute of Child Health, Clinical Neurosciences, London, UK.
  • Rating D; University of Heidelberg, Germany.
  • Schmitt B; Division of Clinical Neurophysiology/Epilepsy, University Children's Hospital, Zurich, Switzerland.
  • Verity CM; PIND Research, Addenbrookes Hospital, Cambridge, UK.
  • Osborne JP; Children's Department, Royal United Hospitals Bath NHS Foundation Trust, Combe Park, Bath, UK; Department for Health, University of Bath, Claverton Down, Bath, UK.
Lancet Neurol ; 16(1): 33-42, 2017 Jan.
Article en En | MEDLINE | ID: mdl-27838190

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Problema de salud: 2_muertes_prevenibles / 6_epilepsy / 7_neonatal_care_health Asunto principal: Espasmos Infantiles / Resultado del Tratamiento / Vigabatrin / Hormonas / Anticonvulsivantes Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Infant / Male Idioma: En Revista: Lancet Neurol Asunto de la revista: NEUROLOGIA Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Problema de salud: 2_muertes_prevenibles / 6_epilepsy / 7_neonatal_care_health Asunto principal: Espasmos Infantiles / Resultado del Tratamiento / Vigabatrin / Hormonas / Anticonvulsivantes Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Infant / Male Idioma: En Revista: Lancet Neurol Asunto de la revista: NEUROLOGIA Año: 2017 Tipo del documento: Article
...